Maintaining Stability: How We're Getting RNA Where It Needs To Go

Combined Therapeutics CSO Thomas Van Cott, Ph.D. and Omega Therapeutics Executive Director, Process Development and Analytical Sciences Jeff Atkinson, Ph.D. discuss stabilization and delivery. In this segment from the Bioprocess Online Live event, mRNA Update: Beyond Prophylactic Vaccines, both panelists share progress on the steps being taken to stabilize and protect RNA therapeutics from manufacturing through CMC and on to patient delivery.